Aberrations aecting the tumor suppressor gene p16
have been described for a variety of tumors. In breast cancer, approximately 50% of tumors show low or lack p16 expression. While evidence provided by some studies has implicated a possible role for p16 in normal replicative senescence, other studies have suggested that the Rb, pathway through which p16 functions, may not be involved in senescence control. Previously we observed that all immortal lines derived from normal mammary epithelium which were analysed for p16 displayed inactivation of this gene through distinct mechanisms, supporting p16 inactivation as a possible necessary event in escape from senescence. To further clarify this issue, we have analysed p16 expression in a panel of normal ®nite lifespan human mammary epithelial cells (HMEC) from initial propagation through growth arrest, using media which confer dierent replicative capacity. Approximately 10 ± 25-fold increase in p16 expression was observed for all normal HMEC with initial onset of a senescence phenotype following 15 ± 25 population doublings in culture. These cells also displayed expression of the senescence associated b-galactosidase. Interestingly, HMEC with additional long term replicative capacity (approximately 80 population doublings) arose from these growth arrested cultures, showing lack of p16 expression. This extended growth capacity appears to be associated with a methylation phenomenon since treatment of these cells with the methylation inhibitor 5-aza-2-deoxycytidine resulted in growth arrest concurrent with reacquisition of p16 expression and senescence associated b-galactosidase. Analysis of p21waf1 expression revealed no change in expression during growth in vitro. These results support p16
Introduction
The p16 INK4a protein, hereafter referred to as p16, is a known negative regulator of cell cycle progression through its cyclin dependent kinase (CDK) inhibiting function (Serrano et al., 1993) . p16 competes with the activating D type cyclins for association with CDK4 or CDK6, thereby preventing phosphorylation of proteins controlling G1 exit such as the retinoblastoma (Rb) protein (Sherr, 1996) . Inactivation of p16 has been observed in numerous tumor types Gonzalez-Zulueta et al., 1995; Herman et al., 1995; Dreyling et al., 1995; Xiao et al., 1995a,b) , and lack or reduced expression of p16 has also been shown through a variety of technical approaches to occur in at least 50% of the breast cancer samples examined (Brenner et al., 1996; Geradts et al., 1995) . While these ®ndings suggest that p16 may play an important role in breast tumorigenesis, the consequence of such aberrations of p16 are not yet clear.
Of the putative functions of p16, the role as a candidate senescence gene is supported by several observations. The mapping of p16 to chromosomal subregion 9p21, a region containing a putative senescence gene, is signi®cant in this regard (Barrett et al., 1994) . Also, p16 is an upstream negative regulator of retinoblastoma protein phosphorylation (Serrano et al., 1993) . Studies by Stein et al. (1990) have shown that replicative ®broblasts phosphorylate Rb upon stimulation with serum following serum starvation, but in senescent ®broblasts, Rb remains unphosphorylated. Analogously, elevated p16 levels are seen in senescent ®broblasts as compared to young ®broblasts, suggesting that Rb remains unphosphorylated in senescent cells due to high levels of p16 (Barrett et al., 1994; Alcorta et al., 1996) . These and other observations suggest p16 may be important in the control of replicative senescence.
Although these observations support a putative role for p16 in the senescence control of ®broblasts, the situation in human mammary epithelial cells has remained less clear. The human papilloma virus 16 (HPV) proteins E6 and E7, which interact with p53 and Rb respectively, are both required for the HPV mediated escape from senescence in ®broblasts leading to immortalization (Shay et al., 1993a) . However, in human mammary epithelial cells, the presence of E6 alone has been found to be sucient for escape from senescence and the induction of an extended replicative capacity leading to immortalization (Band et al., 1991; Shay et al., 1993a) . Further, mammary epithelial cells from patients with Li ± Fraumeni Syndrome (germline mutation of p53) spontaneously immortalize in vitro, while stromal cells from these patients do not . Normal human mammary epithelial cells have also been shown to undergo immortalization when transfected with only a mutant p53 (Gollahon and Shay, 1996) . This has led to the suggestion that, unlike in ®broblasts, the Rb pathway through which p16 exerts its growth suppressive eect is not involved in senescence control of mammary epithelial cells (Shay et al., 1993a,b) . However, in more recent studies, it has been suggested that distinct susceptibility of human mammary epithelial cells to E6/E7 induced escape from senescence may be dependent upon the stage of culture (Wazer et al., 1995) . While escape from senescence has been achieved by HPV 16 E6 alone, this was only seen in cultures with long term growth potential which had emerged from a period of growth arrest termed selection'. In contrast, most early passage cells which had not yet entered selection were immortalized by E7 alone and not E6 (Wazer et al., 1995) . The dierence between these preselection and postselection cell populations which results in distinct susceptibility to viral immortalization has not been clear. Further, the reasons cells arrest growth at this stage, as well as the means of spontaneous escape, have not been elucidated.
We previously observed the inactivation of p16 in immortal breast epithelial lines derived from normal mammary epithelium through three distinct mechanisms; homozygous deletion (MCF10 and MCF12 cell lines) nonsense mutation with hemizygous loss (184 A1 cell line), or hypermethylation (184 B5 cell line) (Brenner and Aldaz, 1995; and unpublished data) . These ®ndings supported p16 inactivation as a possible necessary event for escaping senescence. In this report, we sought to further characterize the role of p16 in senescence control of human mammary cells. Normal primary human mammary epithelial cultures (HMEC) were followed from initial propagation in vitro until growth arrest and subsequent extended replicative growth. Expression analysis of p16, as well as another candidate senescence control gene p21
WAF1
, was performed at various time points. The HMEC were also monitored for replicative capacity and expression of the senescence associated b-galactosidase.
Results

Analysis of p16 in normal HMEC
Normal HMEC in vitro, like normal ®broblasts, undergo a limited number of cell divisions (Stampfer and Yaswen, 1994) . In the case of HMEC, the total number of population doublings which can be achieved, as well as other characteristics, has been shown to be dependent upon the type of media used to propagate the cells (Stampfer and Yaswen, 1994) . Speci®cally, ®nite lifespan HMEC grown in the serum containing medium, MM, display active growth for 2 ± 5 passages or 15 ± 25 population doublings, with gradual loss of proliferative activity. The senescent population retains the typical epithelial morphology (Stampfer, 1985) . In contrast, when HMEC are grown in the serum-free MCDB 170 medium, after active proliferation for 2 ± 3 passages, almost all the cells cease growth, becoming large,¯at, striated, with irregular cell borders (Stampfer, 1985; Hammond et al., 1984) . Following 2 ± 4 weeks of inactivity, the population then undergoes a process termed`selfselection' (Hammond et al., 1984) . There is active proliferation of small cells with the typical epithelial cobblestone morphology, which soon dominate the culture. These post selection cells maintain growth for an additional 7 ± 24 passages (approximately 45 ± 100 population doublings in total), after which¯atter and more vacuolated cells appear which retain the epithelial morphology without further growth (®nal arrest).
To assess the possible role of p16 in HMEC senescence, HMEC from ®ve dierent reduction mammoplasty specimens were cultured in both MM and MCDB 170 and followed from initial propagation through cessation of growth. Initially, the levels of p16 were low in both culture conditions. These levels rose with increasing passage until initial growth arrest, when p16 levels were 10 ± 25-fold higher than original values ( Figures 1a and b and 2 ). In contrast, assay of the emergent post-selection cells in MCDB 170 indicated that the level of p16 transcript was drastically reduced (Figures 1c and d and 2) . None of the post-selection HMEC revealed expression of p16 during the following growth period, nor at the ®nal growth arrest. These ®ndings were con®rmed at the protein level as well. Figure 3 shows an immunoblotting analysis of the 184 HMEC culture using an antip16 antibody. Cells grown in serum containing media (MM) start with low levels of p16 protein expression ( 
Methylation of post-selection HMEC
Previous analysis of tumor cell lines as well as numerous primary tumors has shown inactivation of p16 through de novo methylation of the promoter region . Promoters silenced by methylation can be reactivated in many cases by treatment with 5-aza-2'-deoxycytidine, a drug which is an established inhibitor of DNA methylation. In order to determine whether cells arising after initial arrest in MCDB 170 lacked expression due to methylation, post selection cells were grown in the presence of 5-aza-2-deoxycytidine and evaluated for p16 expression. Of the ®ve post-selection cultures examined, all regained p16 expression following treatment ( Figure 1c ; samples labeled PA, Figure  2 ). Further, analysis of the 184 post-selection cells by methylation-sensitive endonuclease digestion of DNA followed by Southern hybridization with a p16 exon 1 probe, showed patterns consistent with complete methylation of p16, corroborating the aforementioned results (not shown). These data indicate that those cells capable of post-selection growth were inactive in p16 expression due to de novo mthylation.
Coincidence of expression of p16 and senescence associated b-galactosidase
In analysis of senescent cultures, Dimri et al. (1995) observed the expression of an unusual endogenous bgalactosidase with a pH optimum of 6.0. This form of b-galactosidase was expressed by senescent cells in vivo as well as those cultured in vitro, but not by presenescent, quiescent, or terminally dierentiated cells. While the source or function of this novel bgalactosidase is unknown, it nevertheless constitutes a useful senescence associated marker. To establish whether this marker showed coincident expression with growth arrest and increased p16 expression of the HMEC grown in both culture conditions, cells were evaluated at various time points for the presence of senescence-associated b-galactosidase (SA b-Gal).
As expected, analysis of SA b-Gal in the early actively growing HMEC in either MM or MCDB 170 revealed no activity. As previously mentioned, these same cell populations also showed low p16 expression. However, when cells ceased replicating following the 2nd ± 5th passage in both media, high levels of SA bGal were displayed, coincident with the highest levels of p16 (Figure 4a and b) . In contrast, the newly emergent post-selection HMEC from the same cultures in MCDB 170, which had no p16 expression due to apparent hypermethylation of the p16 promoter, did not display SA b-Gal activity positive cells. When these actively growing cells were treated with 5-aza-2-deoxycytidine to reverse methylation, cells ceased growing, regained expression of p16 (as mentioned above), and expression of SA b-Gal was again observed concurrently (Figure 4e ).
Analysis of p21
WAF1 expression with senescence
, has been shown to be induced during senescence in ®broblasts (Alcorta et al., 1996; Levine, 1997) . In order to determine whether p21 expression is associated with senescence of HMEC, levels of p21 expression were followed in the aforementioned cultures. High levels of p21 were observed during initial propagation and showed little variability during growth arrest or extended replicative life ( Figure 5 ). Thus, while increased expression of p21 was seen with senescence in some cell types, this does not appear to be the case with HMEC, suggesting that p21 does not play as signi®cant a role in senescence of HMEC as p16
INK4a
. This is similar to observations in adrenocortical cells, which express high levels of p21 WAF1 throughout their replicative life span to senescence .
Discussion
As previously mentioned, the number of population doublings which can be achieved in the culture of HMEC has been shown to be largely dependent upon Figure 2 Duplex RT ± PCR analysis of p16 expression relative to glyceraldehyde 6-phosphate dehydrogenase (GAPDH) expression in four additional normal human mammary epithelial cultures at initial growth arrest (S), post-growth arrest (PS), and when treated with a methylation inhibitor post-growth arrest (PA). Notice all cultures express high levels of p16 at initial growth arrest, but not following unless treated with a methylation inhibitor Figure 3 Immunoblot analysis of p16 protein expression in normal 184 human mammary epithelial cells. Early in culture, cells grown in serum containing media (MM) show low levels of p16 protein expression (MM passage 2) which increases in subsequent passages and remains high until ®nal growth arrest (MM passage 6). The same HMEC grown in serum-free MCDB170 medium (170) show detectable p16 protein only in pre-selection cells (170, passage 2) but not in post-selection cells (170, passage 20). All lanes were control for equal protein loading (not shown) p16 at senescence and extended life AJ Brenner et al the type of culture media used (Stampfer and Yaswen, 1994) . Nevertheless, all HMEC undergo a period of initial growth arrest at an approximately similar level of growth, from which only those cells grown in serum free media recover. The reason cells undergo this initial growth arrest and the mechanisms by which cells recover from it, have not been understood. In the series of HMEC examined in this report, all showed an increase in p16 expression with progression toward initial growth arrest, at which point the highest levels of p16 were observed. When grown in serum free media, foci of actively growing cells emerged from these seemingly senescent cultures at a low frequency (*10
75
) and were devoid of p16 expression due to possible hypermethylation of the p16 promoter region. These cells did not regain p16 expression at anytime during their remaining replicative period, nor at ®nal growth arrest (Figure 3) . These data would suggest that increased expression of p16 may be causative of the initial growth arrest observed in these cultures. It has been suggested (Foster and Galloway, 1996) that initial growth arrest of HMEC may be indicative of a normal senescence and an early mortality stage which is distinct from those previously postulated in the Shay et al. (1993b) two stage model of human mammary epithelial immortalization. Indeed, the increased expression of p16 in ®broblasts with onset of senescence has been previously described (Alcorta et al., 1996) , and we now show a similar increase with the onset of initial growth arrest in HMEC. Additionally, our ®nding of expression of senescence marker SA bGal in cells at this initial growth arrest, as well as in those post selection cells growth arrested with regain of p16 expression when treated with a methylation inhibitor, adds weight to this prospect. Nevertheless, while SA b-Gal may be the best marker available for determination of senescence, it is not an absolute indicator. Further, SA b-Gal was also observed during the ®nal growth arrest which has classically been viewed as senescence. Additional studies are needed to better address how the initial arrest and ®nal arrest may relate to senescence in vivo.
As previously mentioned, analysis of immortalization of human mammary epithelial cells by E6 and E7 genes has shown susceptibilities distinct to those found in ®broblasts (Shay et al., 1993a) . Therefore, it has been proposed that while both Rb and p53 are involved in ®broblast immortalization, only p53 appeared to play a role in mammary epithelial cells (Shay et al., 1993a,b) . However, it is worth noting that the analysis of susceptibility to immortalization by E6 and E7 was performed with`post-selection' mammary epithelial cells grown in media MCDB 170, which we have now shown to lack p16 expression (Shay et al., 1993a) . This would suggest that the lack of necessity for E7 in immortalization of mammary epithelial cultures is due to prior inactivation of p16, and subsequent alteration of the Rb pathway. In such circumstances, the sequestration of Rb protein by E7 may confer no known additional bene®t. Further, it suggests that similar to ®broblasts, both Rb and p53 dependent pathways play a role in the senescence control of mammary epithelial cells.
In support of this argument, recent studies by Wazer et al. (1995) have revealed that mammary epithelial cells present in milk and grown in a high serum supplemented media, similar to cells grown in serum supplemented media MM which we show to maintain p16 expression, show substantial extension of life span with E7. While E6 was not able to confer a similar extension of life span in these cultures, its presence was required for complete immortalization. Additionally, in similar analysis of susceptibility to E6 and E7 immortalization of pre-selection and post-selection mammary epithelial cultures from tissue grown in media DFCI-1, a medium of constitution similar to MCDB 170 which results in selection, Wazer et al. (1995) were able to demonstrate that most pre-selection HMEC cultures undergo extension of lifespan followed by immortalization with E7 and not E6. In contrast, post-selection HMEC immortalize with E6 and not E7. This was subsequently corroborated by others, and the arrest which E7 is capable of circumventing was designated M0 by Foster and Galloway (1996) to conform to nomenclature previously used in a two stage model of immortalization suggested by Shay et al. (1993a) . Thus, the requirement for E7 in immortalization of cells expressing p16 (pre-selection), and lack of necessity for E7 in the immortalization of mammary epithelial cells with inactivated p16 (postselection), supports the role of p16 as a senescence control gene in human mammary epithelial cells. Additionally, this suggests that a chronology exists in the senescence control of human mammary epithelial cells where increased p16 expression may be involved in an initial stage (M0) of normal growth arrest. Inactivation of this initial control stage (e.g. p16 inactivation or Rb sequestration by E7) appears to result in a limited increase in replicative capacity and suspectibility to further extension of lifespan by circumvention of the second (M1) stage (e.g. by E6 or mutant p53 (Shay et al., 1993a) . Following a ®nal period of selection (crisis, M2) immortal cells emerge. This may by typi®ed by previous experiments such as those of spontaneous immortalization of post-selection (grown in MCDB 170) mammary epithelial cells from Li ± Fraumeni patients, while ®broblasts from these same patients required E7 to immortalize . Adaptation of previously suggested two stage models of mammary epithelial cell immortalization to include a ®rst step dependent upon Rb pathway inactivation might be necessary.
In conclusion, in this report we show an increase in expression of p16 with HMEC growth in vitro, the highest levels of p16 expression coinciding with the ®rst growth arrest and expression of a senescence marker, SA b-Gal. Cells emerged from these seemingly senescent cultures devoid of p16 expression possible due to hypermethylation of the p16 promoter region. No change was seen in p21 WAF1 expression from initial propagation through the entire culture period. These results support p16 as well as the Rb pathway in the senescence control of normal mammary epithelial cells. Further, these results provide insight into the possible reason for dierences between stromal and epithelial cells observed in previous studies of induced extended life utilizing cells which have undergone`selection' in serum free media.
Materials and methods
Cell culture
Normal human breast tissue specimens from reduction mammoplasties were obtained and epithelial organoids were separated from stromal components as previously described (Stampfer et al., 1980) . Organoids were cultured in parallel in either a complex serum containing medium, MM (Stampfer, 1982 (Stampfer, , 1985 , containing 0.5% fetal bovine serum, conditioned media from the cell line Hs767B1 (30%), insulin (10 mg/ml), hydrocortisone (0.1 mg/ml), epidermal growth factor (5 ng/ml), and cholera toxin (1 ng/ml), or in the serum free medium MCDB 170 (23,24) supplemented with insulin (5 mg/ml), hydrocortisone (0.14 mM), epidermal growth factor (10 ng/ml), transferrin (5 mg/ml), isoproterenol (1 mM) and bovine pituitary extract (70 mg/ml).
For analysis of methylation, 5-aza-2'-deoxycytidine was added to a ®nal concentration of 3.3 mM for 72 ± 96 h.
DNA and RNA extraction
Total genomic DNA was isolated using phenol : chloroform : isoamyl alcohol (25 : 24 : 1) in Phase Lock Gel tubes (5 Prime?3 Prime, Boulder, CO), according to standard protocol, and precipitated with 2.5 volumes ethanol. Total RNA was isolated using an RNEasy Total RNA kit (Qiagen, Chatsworth, CA) as per manufacturers instruction.
Southern analysis for hypermethylation
Methylation analysis was performed as previously described (Brenner et al., 1996) . Brie¯y, 10 mg of genomic DNA were digested with a¯anking site enzyme (either EcoRI or HindIII) and a methylation sensitive endonuclease (SacII, SmaI and EagI). The digested fragments were ethanol precipitated, resuspended and resolved in 1% agarose gel overnight. DNA was transferred to a ZetaProbe nylon membrane (BioRad, Richmond, CA) and hybridized with a 340 bp or 280 bp a-32 P-dCTP random prime labeled PCR fragment including exon 1a, as described . Autoradiographs were obtained following 2 ± 4 days of exposure.
Duplex RT ± PCR
Five mg of total RNA were used for ®rst strand cDNA synthesis with Superscript II reverse transcriptase (Gibco BRL, Gaithersburg, MD) as per manufacturers instructions. Following reverse transcription, 4 ml (1/15 of total) each sample was subjected to ampli®cation with 200 mM each primer, 2.0 mM MgCl 2 , 16Taq Buer, 10% dimethylsulfoxide, 0.7 mM dNTPs, in a ®nal volume of 20 ml. Following a 5 min denaturing at 968C, samples were held at 908C while ®ve units of Taq DNA Polymerase (Promega) were added, followed by 20 cycles at 948C, 508C, and 728C for 40 s each. Reaction products were diluted 50-fold, and subjected to an additional 13 cycles (p16) or ten cycles (p21) of ampli®cation utilizing one nested 32 P-polynucleotide kinase end labeled primer per reaction product, employing the same conditions as the ®rst ampli®cation. Reaction products were resolved on 5% (1 : 30) native polyacrylamide, followed by autoradiography. Signal intensities in all cases were analysed and quanti®ed with a Molecular Dynamics Phosphorimager.
Primers used were as follows: GAPDH 5', CCGATGG-CAAATTCGAT GGC; GAPDH 3', GATGACCCTTTT-GGCTCCCC; P16 5', CAACGCACCGA ATAGTTACG; P16 3'(1), AGCACCACCAGCGTGTC; P16 3'(2), CGT-GTCCA GGAAGCCC; GAPDH 3'(P21), CAGAGATGAT-GACCCTTTTGGC; P21 5'(1), CAGCAGGAAGACCAT-GGTG; P21 5'(2), GACCTGTCACTGTCTTGTACC; P21 3', CCTGTGGGCGGATTAGGGCTTCC.
Immunoblot analysis
Protein expression analysis was performed using an antip16 antibody as previously described (Sandhu et al., 1997) .
SA B-Gal activity staining
Cells were washed 26 with PBS, ®xed in neutral buered formalin, and stained as previously described (Dimri et al., 1995) . Brie¯y, following ®xation, cells were incubated overnight at 378C in a reaction buer containing X-gal (1 mg/ml), 40 mM citric acid/sodium phosphate (pH 6.0), potassium ferrocyanide/ferricyanide (5 mM), NaCl (150 mM) and 2 mM MgCl 2 . Negative activity control was breast carcinoma line T47D and positive activity control were senescent diploid ®broblasts.
